KDR and neoplasm: 3.2. OLFML3 Is Highly Expressed in CRC Patient-Derived Tumor Xenografts and Is Downregulated by Anti-VEGF-A/-VEGFR-2 Therapies in Mouse and Human CRC Transplant Models